Literature DB >> 33755710

Phage susceptibility testing and infectious titer determination through wide-field lensless monitoring of phage plaque growth.

Prisca Perlemoine1, Pierre R Marcoux1, Emmanuel Picard2, Emmanuel Hadji2, Marc Zelsmann3, Grégoire Mugnier3, Aurélie Marchet4, Grégory Resch4, Larry O'Connell5, Eric Lacot6.   

Abstract

The growing number of drug-resistant bacterial infections worldwide is driving renewed interest in phage therapy. Based on the use of a personalized cocktail composed of highly specific bacterial viruses, this therapy relies on a range of tests on agar media to determine the most active phage on a given bacterial target (phage susceptibility testing), or to isolate new lytic phages from an environmental sample (enrichment of phage banks). However, these culture-based techniques are still solely interpreted through direct visual detection of plaques. The main objective of this work is to investigate computer-assisted methods in order to ease and accelerate diagnosis in phage therapy but also to study phage plaque growth kinetics. For this purpose, we designed a custom wide-field lensless imaging device, which allows continuous monitoring over a very large area sensor (3.3 cm2). Here we report bacterial susceptibility to Staphylococcus aureus phage in 3 hr and estimation of infectious titer in 8 hr 20 min. These are much shorter time-to-results than the 12 to 24 hours traditionally needed, since naked eye observation and counting of phage plaques is still the most widely used technique for susceptibility testing prior to phage therapy. Moreover, the continuous monitoring of the samples enables the study of plaque growth kinetics, which enables a deeper understanding of the interaction between phage and bacteria. Finally, thanks to the 4.3 μm resolution, we detect phage-resistant bacterial microcolonies of Klebsiella pneumoniae inside the boundaries of phage plaques and thus show that our prototype is also a suitable device to track phage resistance. Lensless imaging is therefore an all-in-one method that could easily be implemented in cost-effective and compact devices in phage laboratories to help with phage therapy diagnosis.

Entities:  

Year:  2021        PMID: 33755710      PMCID: PMC7987195          DOI: 10.1371/journal.pone.0248917

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  35 in total

1.  Replication of viruses in a growing plaque: a reaction-diffusion model.

Authors:  J Yin; J S McCaskill
Journal:  Biophys J       Date:  1992-06       Impact factor: 4.033

2.  Ultra wide-field lens-free monitoring of cells on-chip.

Authors:  Aydogan Ozcan; Utkan Demirci
Journal:  Lab Chip       Date:  2007-11-01       Impact factor: 6.799

3.  Observations on bacteriophage typing of Pseudomonas aeruginosa.

Authors:  B POSTIC; M FINLAND
Journal:  J Clin Invest       Date:  1961-11       Impact factor: 14.808

4.  Efficacy of newly isolated and highly potent bacteriophages in a mouse model of extensively drug-resistant Acinetobacter baumannii bacteraemia.

Authors:  Lika Leshkasheli; Mzia Kutateladze; Nana Balarjishvili; Darejan Bolkvadze; Jonathan Save; Frank Oechslin; Yok-Ai Que; Grégory Resch
Journal:  J Glob Antimicrob Resist       Date:  2019-05-14       Impact factor: 4.035

Review 5.  The isolation of bacteriophages from the environment.

Authors:  N D Seeley; S B Primrose
Journal:  J Appl Bacteriol       Date:  1982-08

6.  Rapid concentration of bacteriophages from aquatic habitats.

Authors:  S B Primrose; M Day
Journal:  J Appl Bacteriol       Date:  1977-06

7.  Population Dynamics of Phage and Bacteria in Spatially Structured Habitats Using Phage λ and Escherichia coli.

Authors:  Namiko Mitarai; Stanley Brown; Kim Sneppen
Journal:  J Bacteriol       Date:  2016-05-27       Impact factor: 3.490

8.  Use of phages against antibiotic-resistant Staphylococcus aureus isolated from bovine mastitis.

Authors:  R S Dias; M R Eller; V S Duarte; Â L Pereira; C C Silva; H C Mantovani; L L Oliveira; E de A M Silva; S O De Paula
Journal:  J Anim Sci       Date:  2013-07-26       Impact factor: 3.159

9.  Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence.

Authors:  Frank Oechslin; Philippe Piccardi; Stefano Mancini; Jérôme Gabard; Philippe Moreillon; José M Entenza; Gregory Resch; Yok-Ai Que
Journal:  J Infect Dis       Date:  2017-03-01       Impact factor: 5.226

10.  Phage-Antibiotic Synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth.

Authors:  André M Comeau; Françoise Tétart; Sabrina N Trojet; Marie-Françoise Prère; H M Krisch
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

View more
  1 in total

Review 1.  Determination of phage susceptibility as a clinical diagnostic tool: A routine perspective.

Authors:  Valéry Daubie; Houssein Chalhoub; Bob Blasdel; Hafid Dahma; Maya Merabishvili; Tea Glonti; Nathalie De Vos; Johan Quintens; Jean-Paul Pirnay; Marie Hallin; Olivier Vandenberg
Journal:  Front Cell Infect Microbiol       Date:  2022-09-21       Impact factor: 6.073

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.